Immediate Impact

1 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Standout
Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation
2023 Standout
1 intermediate paper

Works of Ulla Roggenbuck being referenced

Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners
2013
Was bedeuten Gehstreckenbestimmungen bei peripherer arterieller Verschlußkrankheit auf dem Laufband und im Alltag?
1999

Author Peers

Author Last Decade Papers Cites
Ulla Roggenbuck 441 367 319 48 1.3k
M Tedesco 401 691 85 56 1.5k
Daniela Militianu 231 337 205 40 1.1k
Mehmet Yazıcı 809 311 252 80 1.6k
Jan Janzen 235 365 76 31 1.2k
Y. L. Chan 203 429 70 43 1.3k
Mustafa Taşar 201 552 107 67 1.2k
J Zalewski 610 393 99 78 1.2k
Osman Turak 686 342 162 60 1.4k
Mark E. O’Donnell 208 670 63 82 1.2k
Naveen Garg 292 181 130 61 994

All Works

Loading papers...

Rankless by CCL
2026